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Abstract 
Tuberculosis (TB) is a major public health problem in Nigeria. This study was aimed at providing 
information on haematological changes in pulmonary tuberculosis (PTB) infection. One hundred PTB 
patients aged 15-45 years, attending tuberculosis clinics in Calabar, Nigeria were studied while 70 
apparently healthy subjects served as controls.  Standard techniques were used for the assays. Results 
showed significantly lower values of Packed cell volume(PCV), haemoglobin concentration(Hb), mean 
cell haemoglobin(MCH), mean cell haemoglobin concentration(MCHC) (p<0.05) in PTB while mean 
cell volume(MCV), erythrocyte sedimentation rate (ESR), relative plasma viscosity (RPV), euglobulin 
lysis time (ELT) and fibrinogen concentration showed significantly higher values in PTB patients than 
that of control subjects. ESR, RPV and ELT decreased significantly (p<0.05) as anti-tuberculosis 
therapy progressed. PCV, HB, MCV, MCH, MCHC and ESR of PTB patients co-infected with HIV 
changed significantly (p<0.05). Anaemia, increased haemorheologic activity and reduced fibrinolysis 
occur in pulmonary tuberculosis.  
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 Introduction 
Tuberculosis (TB), one of the oldest known diseases and still a major cause of mortality today, has 
many manifestations affecting the bone, the central nervous system and many other organ systems, but 
it is primarily a pulmonary disease. It is caused by a closely-related group of organisms, all of which 
form the Mycobacterium tuberculosis complex. These organisms include M. tuberculosis, M. bovis, M. 
africanum, M. microfti and M. Canetti (Iseman, 2000). Pulmonary tuberculosis (PTB) is a lower 
respiratory tract infection that is initiated by the deposition of Mycobacterium tuberculosis (MTB) 
contained in aerosol droplets, onto lung alveolar surfaces. The active disease is characterized by a 
protracted cough, fatigue, loss of weight and appetite and night sweats. Haemoptysis, secondary 
infection by fungi and permanent lung damage are few of the complications of PTB (Fraser, 1993). 
Tuberculosis is a major public health problem in Nigeria with an estimated prevalence of 616 cases per 
100,000. Nigeria ranks first in Africa and fourth among the 22 high TB burden countries in the world. 
No fewer than 460,000 cases of tuberculosis are reported annually in Nigeria (WHO, 2008). The co-
infection of pulmonary tuberculosis with human immune deficiency virus (HIV) and acquired immune 
deficiency syndrome (AIDS) has in the recent past compounded the epidemiology, clinical outcome, 
diagnosis and treatment of the disease worldwide (CDC, 1995).This has led to the different reports 
made for this condition in Nigeria. Previous study has shown that anaemia, raised erythrocyte 
sedimentation rate (ESR), peripheral leukocyte count and neutrophilia are the most common 
haematological manifestations associated with PTB (Devi et al, 2003). Another study carried out in 
Kano, Northern Nigeria, reported mild anaemia, and raised ESR, leucocytosis, neutrophilia with toxic 
granulation, thrombocytosis, occasional stickiness of platelets and monocytosis (Nwankwo et al, 2005). 
In Benin, Southern Nigeria, a study showed significant increase in plasma viscosity and fibrinogen 
levels and a decrease in platelet count, total white cell count and packed cell volume when compared to 
values for apparently healthy subjects (Awodu et al, 2007). It is our aim to study the pattern of some 
haematological parameters in PTB infected subjects in Calabar Nigeria. It is believed that the findings 
of this study may be useful as indicators of disease progression, cardiovascular risk factors and 
response to therapy in pulmonary tuberculosis  
Materials and Methods  
 A total of one hundred (100) male and female pulmonary tuberculosis patients aged between fifteen to 
forty five (15-45) years, attending the Endemic Disease Clinics of University of Calabar Teaching 
hospital and Dr Lawrence Henshaw Memorial Hospital, Calabar, Nigeria were selected for the study. 
With approval from the ethical committee of both hospitals, the bio data and medical history of these 
patients were obtained from their case notes. Subjects who were diagnosed as pulmonary tuberculosis 
patients based on the presence of the acid fast bacilli in their sputum smear were included while those 
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who were smear negative were not enrolled in the study. The HIV status of the patients was determined 
during selection. Seventy (70) age and gender-matched apparently healthy individuals who tested 
negative with acid fast bacilli in their sputum smear and HIV sero-negative were used as control 
subjects in this research. They were selected from staff of University of Calabar, University of Calabar 
Teaching Hospital and residents of Calabar municipality. Informed consent was sought and obtained 
from all participants. 
 Six and a half millilitres (6.5 ml) of blood was collected under aseptic conditions with minimal stasis 
from each subject. 4.5 ml was added to ethylene diamine tetra acetic acid anticoagulant with a 
concentration of 1.5 mg/ml for determination of  packed cell volume (PCV), haemoglobin (Hb), mean 
cell volume (MCV), mean cell haemoglobin (MCH,) mean cell haemoglobin  concentration ( MCHC) 
white blood cell (WBC) and platelet counts, using PCE 2000 automatic cell counter, erythrocyte 
sedimentation rate by Westergren technique(ICSH,1993) and relative plasma viscosity by Reid and 
Ugwu(Reid and Ugwu,1987), while the remaining 2 ml was added to 0.22 ml of 3.13% trisodium 
citrate for euglobulin lysis time test using  Haugie (Haugie,1986), method and fibrinogen concentration 
using kit based on Clauss method (Clauss,1999) purchased from BAUR company USA. The data 
generated from this work were subjected to student t-test analysis and one-way analysis of variance.  A 
two tailed P-value of < 0.05 was considered indicative of a statistically significant difference. 
 
 Results 
In this study, some haematological parameters of pulmonary tuberculosis patients in Calabar were 
investigated. The tests that were performed included measurement of packed cell volume, haemoglobin 
concentration ,mean cell haemoglobin, mean cell haemoglobin concentration, mean cell volume,  
erythrocyte sedimentation rate, white blood cell and platelet counts, relative plasma viscosity, 
euglobulin lysis time and fibrinogen concentration. The results obtained were compared with 
apparently healthy subjects (controls).  
Table 1 shows the mean values of the various parameters that were analysed. The mean values obtained 
for HB, PCV, MCH and MCHC of PTB patients were significantly lower (p<0.05) than values 
obtained for control subjects. While the mean MCV relative plasma viscosity, euglobulin lysis time and 
fibrinogen concentration and erythrocyte sedimentation rate of PTB patients were significantly higher 
(p<0.05) than that of control subjects. The WBC and platelet counts of PTP did not change 
significantly from that observed for the control subjects.  
Table 2 shows the means and standard deviations of the haematological variables of pulmonary 
tuberculosis patients based on duration of therapy.  22 were newly diagnosed patients, 34 had been on 
treatment for two to eight (2-8) weeks, 21 for nine to twenty (9-20) weeks and 23 for twenty-one to 
thirty two (21-32) weeks. The erythrocyte sedimentation rate, relative plasma viscosity and euglobulin 
lysis time parameters decreased significantly (p<0.05) as therapy progressed. The haemoglobin 
concentration increased steadily as the treatment progressed though not significantly. There was no 
difference (p>0.05) among the mean values obtained for white blood cell MCH, MCHC,MCV, platelet 
counts, packed cell volume and fibrinogen concentration. Table 3 shows the haematological variables 
of 22 HIV sero-positive pulmonary tuberculosis patients compared with 78 counterparts who were 
sero-negative for HIV infection. Aside from the WBC, Platelet count, RPV, ELT and Fibrinogen 
concentration which did not change significantly, the  PCV, Hb,  MCV, MCH, MCHC and ESR of the 
sero -positive patients changed  significantly (p<0.05)  when compared with those who are sero- 
negative.  
 There was a negative correlation (r=0.558; p<0.05) between packed cell volume and erythrocyte 
sedimentation rate and packed cell volume and relative plasma viscosity (r=0.447; p<0.05) (figs1 and 
2).On the other hand, a positive correlation (r=0.209; p<0.05) between relative plasma viscosity and 
erythrocyte sedimentation rate was observed (Fig3). 
Discussion 
 Pulmonary tuberculosis (PTB) is a major infectious disease with very high incidence in developing 
countries and this is expected to rise with the incidence of HIV infection. Severe pulmonary 
tuberculosis (PTB) is often complicated by deep vein thrombosis (DVT) because of the association 
between inflammation and haemostatic changes that can result in an acute phase response and a 
hypercoagulable state. Deep vein thrombosis has been clinically observed and confirmed with 
laboratory methods in 3–4% of patients with pulmonary tuberculosis (Robson, 1996). Some 
haematological variables of one hundred (100) pulmonary tuberculosis patients were investigated in 
this study. While the haemoglobin concentration, packed cell volume, mean cell haemoglobin and 
mean cell haemoglobin concentration of pulmonary tuberculosis patients (12.71 ±2.15g/dl, 
0.36±0.05L/L, 27.93±3.18pg, 34.76±1.55g/l) was significantly lower (p<0.05) than that of control 
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subjects (14.20±1.52g/dl, 0.40±0.04L/L, 29.50±2.38pg, 35.47±1.41g/l), the mean cell volume was 
(80.15±7.84fl significantly higher than that of control subjects (76.06±4.84fl).  Ajayi et al, 2005 
reported significant decreases in these haematological parameters of PTB patients. Anaemia, which is a 
reduction in haemoglobin concentration and by implication PCV, alongside the absolute values (MCV, 
MCH and MCHC), have been reported in some studies (Robson, 1996, Turken et al, 2002). This 
anaemia has been classified as normocytic normochromic anaemia with all the characteristics of 
anaemia of chronic disorders (Nwankwo et al, 2005). Pulmonary tuberculosis being a chronic ailment, 
impacts on the haemopoietic system leading to a decrease in erythropoeisis. Although Ajayi et al. 2005 
and Nwankwo et al 2005) reported lower PCV in their studies, our PCV value is higher than the values 
of their studies. This is probably due to the local diet in Calabar which consists of leafy vegetables and 
sea foods (fish, snails, crayfish, and periwinkle). These iron-containing foods are available at all 
seasons as compared to Kano and Benin towns in Nigeria (Nwankwo et al 2005,) where their staple 
diets consist of food with little or no vegetables and sea foods. This finding thus implies that diet of 
patients to a greater extent plays an important role in the outcome of their haemoglobin concentration.   
The PCV of PTB patients correlated negatively with the ESR and RPV (Figures1 &2) thus indicating 
the relationship between packed cell volume and ESR and RPV.       
 
The ESR and RPV values of PTB patients (44.0±40.0 mm/hr; 2.16±0.62) obtained in this study were 
significantly higher than control values (8.0±7.8 mm/hr & 1.62±0.31). This agrees with previous 
findings (Ibeneme et al, 2009, Ajayi et al. 2005). ESR is often raised in infections and inflammatory 
conditions. Increase in ESR and RPV could be attributed to increased production of acute phase 
proteins often observed in chronic infections and release of proteins by the causative organism (M. 
tuberculosis) into the circulation. Raised plasma viscosity has been reported to cause sluggish flow in 
microcirculation resulting in insufficient tissue perfusion (Grigoleit et al, 1973). This increase in ESR 
and RPV implies that there is increased rheology of blood in pulmonary tuberculosis. This is confirmed 
by a moderate positive correlation (r=0.209; p<0.05) observed between relative plasma viscosity and 
erythrocyte sedimentation rate (Fig3). From this observation one may suggest that both erythrocyte 
sedimentation rate and relative plasma viscosity could be used as sensitive index of plasma protein 
changes which result from inflammation or tissue damage. The euglobulin lysis time of PTB patients 
(227.12±64.08 minutes) was significantly higher (p<0.05) than the control value (172.77±48.81 
minutes). A similar finding has been made (Famodu et al, 2005). A possible explanation is that 
tuberculosis might enhance the local production and release of pro-inflammatory cytokines, which in 
turn reduces fibrinolytic activity.  A reduction in fibrinolysis can lead to the development of venous 
thrombosis in these PTB patients. 
 
The fibrinogen concentration of the PTB patients (6.30±2.50 g/L) was significantly higher (p<0.05) 
than control values (3.17±0.55).  A possible explanation is that the vascular endothelium could be 
primed as a result of the interaction between mycobacterial products and the hostmonocyte-
macrophage system, which then synthesise large amounts of tissue necrotic factor (TNF-alpha) and 
interleukin six (IL-6) (Ogawa et al, 1991,Rook and Attiyah,1991). These cytokines induce hepatic 
acute-phase responses that alter levels of coagulation proteins such as fibrinogen (Andus and Gerok, 
1991). Fibrinogen is an acute-phase reactant which increases greatly in inflammatory and degenerative 
conditions such as PTB. It has been shown that the risk of deep vein thrombosis (DVT) is significantly 
(four times) higher in patients with a fibrinogen level over 5 g/L (Koster, 1993). In the present study, 
the fibrinogen level obtained for the patients is 6.30g/L. This implies that PTB patients may develop 
deep vein thrombosis as a result of the hyperfibrinogenaemia and impaired fibrinolysis observed. In 
this study, the mean white cell and platelet count of PTB patients was 5.3±2.2 × 109/L and 161.2±73.3 
× 109/L and this showed no difference with control values. This result agrees with the mean white cell 
count (5.6±0.4 × 109) obtained in the same locality ( Ibeneme et al, 2009) and disagrees with 
leucocytosis and thrombocytosis that have been reported previously(Robson et al, 1996). It is also at 
variance with a report of decreased white cell and platelet counts in PTB patients (Awodu et al, 2007). 
However, most of the pulmonary tuberculosis patients enrolled in this study where those undergoing 
anti-tuberculosis treatment and this may account for the disparity in results.  
  
The rheologic and fibrinolytic activity of PTB patients improves as therapy progresses. The ESR 
decreased significantly from 67.0± 34.0 mm/hr for newly diagnosed patients to 26.0± 33.0 mm/hr for 
patients who had been treated for 21-32 weeks (p<0.05). Similarly, the relative plasma viscosity 
decreased significantly from 2.47±0.73 to 1.89±0.38 as therapy progressed. Euglobulin lysis time 
decreased significantly (p<0.05) from 256.46±68.99 minutes at diagnosis to 204.35±42.78 minutes at 
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more than twenty weeks of therapy. However numerically a decrease in the fibrinogen level from 
7.07±2.65 g/L for new patients to 5.93±2.54 g/L after twenty weeks of therapy was observed but this 
difference was not statistically significant. These findings agree with reports of Turken et al (2002) and 
Famodu et al, 2005. In their reports a decrease in ESR, plasma fibrinogen and euglobulin lysis time 
within twelve weeks of anti-tuberculous treatment was observed. Therefore treatment on time reduces 
the risk of deep vein thrombosis for PTB patients as shown by the improved ESR, RPV, ELT and 
fibrinogen levels. The Haemoglobin concentration of these patients steadily improved with therapy.  Of 
the 100 pulmonary tuberculosis patients enrolled in this study, 22 were HIV sero-positive giving a 22 
per cent prevalence rate while78 were HIV sero-negative. The 22 per cent prevalence rate of HIV co-
infection observed in this study is similar to that reported by the National Tuberculosis and Leprosy 
Control Programme of Nigeria (NTBLCP, 2008). The Hb, PCV and MCHC of the sero-positive 
patients was significantly lower (p<0.05) than that obtained for the sero-negative patients while the 
ESR of the sero-positive patients was significantly higher (p<0.05) than that of the sero-negative 
patients. These differences may be due to the impact of HIV infection on the alveolar macrophages 
thereby enhancing the pathogenesis of pulmonary tuberculosis. The mean values obtained for white 
cell and platelet counts, mean cell volume, mean cell haemoglobin relative plasma viscosity, 
euglobulin lysis time and fibrinogen of the sero-positive patients were similar (p>0.05) to those of the 
sero- negative patients. In conclusion this study has established significant changes in haematological 
variables studied in pulmonary tuberculosis patients. While significantly reduced Hb and PCV was 
common feature in TB patients, significantly increased haemorheologic activity( as represented by 
raised ESR & RPV) and reduced fibrinolytic activity(as represented by raised ELT)  were also 
observed in pulmonary tuberculosis patients thus pre-disposing them to thrombosis and vascular 
complications. We therefore suggest the inclusion of relative plasma viscosity, euglobulin lysis time 
and fibrinogen concentration assays as part of routine test for all pulmonary tuberculosis patients in 
order to properly monitor response to therapy and prevent venous thrombosis and its complications. 
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